1. P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL). (23rd June 2022) Authors: Locatelli, F.; Zugmaier, G.; Rizzari, C.; Morris, J.; Gruhn, B.; Klingebiel, T.; Parasole, R.; Linderkamp, C.; Flotho, C.; Petit, A.; Micalizzi, C.; Zeng, Y.; Desai, R.; Kormany, W.; Eckert, C.; Möricke, A.; Sartor, M.; Hrusak, O.; Peters, C.; Saha, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗